Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 2
1999 1
2000 1
2001 2
2003 1
2006 1
2008 2
2009 1
2010 1
2011 1
2012 1
2013 1
2015 3
2016 1
2017 1
2019 2
2020 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs.
Stefanutti C, Julius U, Watts GF, Harada-Shiba M, Cossu M, Schettler VJ, De Silvestro G, Soran H, Van Lennep JR, Pisciotta L, Klör HU, Widhalm K, Moriarty PM; MIGHTY MEDIC Multinational Society. Stefanutti C, et al. J Clin Lipidol. 2017 Jul-Aug;11(4):858-871.e3. doi: 10.1016/j.jacl.2017.04.114. Epub 2017 Apr 25. J Clin Lipidol. 2017. PMID: 28572002 Free article. Review.
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.
Leone G, Baldini V, Bramanti S, Crocchiolo R, Gattillo S, Ermini S, Giudice V, Ferrero I, Moscato T, Milani R, Gozzer M, Piccirillo N, Tassi C, Tassi V, Coluccia P. Leone G, et al. Among authors: gozzer m. Blood Transfus. 2023 Nov 23;21(6):514-525. doi: 10.2450/BloodTransfus.471. Blood Transfus. 2023. PMID: 37146295 Free PMC article.
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
La Rocca U, Perrone MP, Piciocchi A, Barberi W, Gesuiti P, Laurenti L, Cinti P, Gozzer M, Bafti MS, Carmini D, Cinelli N, Cavallari C, Giovannetti G, Ricci R, Girelli G, Foà R, Martelli M, Coluzzi S, Iori AP. La Rocca U, et al. Among authors: gozzer m. Blood Transfus. 2024 Mar;22(2):157-165. doi: 10.2450/BloodTransfus.464. Epub 2023 Sep 21. Blood Transfus. 2024. PMID: 37847211 Free PMC article.
Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients.
La Rocca U, Barberi W, Di Rocco A, Giovannetti G, Neri A, Santilio I, Carmini D, Quattrocchi L, Gozzer M, Bafti MS, Ricci R, Girelli G, Foà R, Iori AP, Coluzzi S. La Rocca U, et al. Among authors: gozzer m. Blood Transfus. 2022 Sep;20(5):404-413. doi: 10.2450/2022.0289-21. Epub 2022 Apr 19. Blood Transfus. 2022. PMID: 35543676 Free PMC article.
Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
La Rocca U, Perrone MP, Piciocchi A, Cinti P, Barberi W, Gozzer M, Baftii MS, Torelli GF, Quattrocchi L, Gesuiti P, Lattanzi R, Cavallari C, Ricci R, Laurenti L, Foà R, Girelli G, Iori AP. La Rocca U, et al. Among authors: gozzer m. Bone Marrow Transplant. 2019 Oct;54(10):1717-1720. doi: 10.1038/s41409-019-0497-1. Epub 2019 Mar 4. Bone Marrow Transplant. 2019. PMID: 30833741 No abstract available.
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
Torelli GF, Rozera C, Santodonato L, Peragine N, D'agostino G, Montefiore E, Napolitano MR, Monque DM, Carlei D, Mariglia P, Pauselli S, Gozzer M, Bafti MS, Girelli G, Guarini A, Belardelli F, Foà R. Torelli GF, et al. Among authors: gozzer m. Blood Transfus. 2015 Jul;13(3):464-71. doi: 10.2450/2015.0231-14. Epub 2015 Jan 30. Blood Transfus. 2015. PMID: 25761309 Free PMC article. Clinical Trial.
26 results